Oxyalkylene phosphate compounds and uses thereof
CA 2283162 A1 · Owner: Nudelman, Abraham · Inventors: Nudelman, Abraham; Rephaeli, Ada
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
This invention relates to compositions for and methods of treating preventing , or ameliorating cancer and other proliferative diseases as well as methods of inducing wound healing, treating cutaneous ulcers treating gastrointestinal , disorders, treating blood disorders such as anemias immunomodulation, enhancing recombinant gene expression treating insulin-dependent patients, treating cystic fibrosis patients inhibiting telomerase activity, treating virus-associated tumors, especially EBV-associated tumors modulating gene , expression and in particular augmenting expression of tumor suppressor genes inducing tolerance to antigens, treating preventing or ameliorating protozoan , …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed March 11, 1998. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended March 11, 2018.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by March 11, 2020.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.